GSC
RMD icon

G&S Capital’s ResMed RMD Stock Holding History

G&S Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,474
Closed -$555K – 161
2026
Q1 		$555K Sell
2,474
-81
-3% -$20.2K 0.2% 102
2025
Q4 		$615K Buy
2,555
+35
+1% +$8.95K 0.22% 99
2025
Q3 		$690K Sell
2,520
-12
-0.5% -$3.28K 0.26% 93
2025
Q2 		$653K Sell
2,532
-45
-2% -$10.7K 0.26% 91
2025
Q1 		$577K Buy
+2,577
New +$602K 0.24% 94

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

G&S Capital's RMD Position: Q2 2026 in Review

G&S Capital sold out of ResMed (RMD) in Q2 2026, closing a stake of 2,474 shares — an estimated $555K sold.

G&S Capital first reported a position in RMD in Q1 2025 and held it in 5 quarters. The position peaked at $690K in Q3 2025. 103 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • G&S Capital reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • G&S Capital sold 2,474 ResMed shares in Q2 2026, an estimated $555K.
  • G&S Capital first reported a position in ResMed in Q1 2025 and held it in 5 quarters.
  • G&S Capital's ResMed position peaked at $690K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.